Action PROK PROKIDNEY CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues ProKidney Corp.

Actions

PROK

KYG7S53R1049

Cours en clôture Nasdaq
Autres places de cotation
 00:00:00 12/06/2024 		Varia. 5j. Varia. 1 janv.
2,99 USD +23,55 % Graphique intraday de ProKidney Corp. -18,75 % +67,98 %
12/06 ProKidney fixe le prix d'un placement d'actions élargi de 130 millions de dollars MT
11/06 Les plus fortes baisses de la mi-journée MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
ProKidney Prices Upsized $130 Million Stock Offering
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
Top Midday Decliners
Wall Street Set to Open Lower Tuesday as Investors Await Fed Decision, Inflation Data
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Top Premarket Decliners
ProKidney Launches $125 Million Stock Offering; Shares Fall After-Hours
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
Sector Update: Health Care Stocks Decline Premarket Monday
ProKidney : Corporate Update Conference Call Presentation
ProKidney Corp. Announces Positive Interim Regen-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
ProKidney Reports 'Positive Interim Results' for Potential Chronic Kidney Disease Treatment
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
ProKidney to Participate in the Jefferies Global Healthcare Conference
ProKidney : Virtual KOL Presentation
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
ProKidney Q1 Loss Unchanged From Year Earlier
ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PROK
  4. Actualités ProKidney Corp.
  5. Autres langues